Rufloxacin
From Wikipedia, the free encyclopedia
This article relies largely or entirely upon a single source. (August 2014) |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
oral |
ATC code | J01MA10 (WHO) |
Legal status | |
Legal status | |
Identifiers | |
|
|
Synonyms | 7-Fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid |
CAS Number | 101363-10-4 106017-08-7 |
PubChem (CID) | 58258 |
ChemSpider | 52489 |
UNII | Y521XM2900 |
ChEMBL | CHEMBL295619 |
Chemical and physical data | |
Formula | C17H18FN3O3S |
Molar mass | 363.406 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) (verify) |
Rufloxacin is a quinolone antibiotic.[1] It is sold under the brand names, Ruflox, Monos, Qari, Tebraxin, Uroflox, Uroclar.
See also[edit]
References[edit]
- ^ Rafalsky, V.; Andreeva, I.; Rjabkova, E. (2006). "Quinolones for uncomplicated acute cystitis in women.". Cochrane Database Syst Rev. 3: CD003597. doi:10.1002/14651858.CD003597.pub2. PMID 16856014.
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |